Overview

Skip to main content

SEC Filings

Overview

Selecting the value will change the page content

SEC Filings year and filing type Select Year: Filter filing type:

Date Filing Type Filing Description Download / View

Quick Links

Viridian Therapeutics
SEC Filings
Events & Presentations
Quarterly Results

IR Contact

Louisa Stone
Manager, Investor Relations

contact us by phone 617-272-4604
IR@viridiantherapeutics.com

Media Contact

Media@viridiantherapeutics.com

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Viridian Therapeutics, Inc., we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Viridian Therapeutics, Inc. to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News
Quarterly Reports
Annual Reports
SEC Filings
End of Day Stock Quote
Events & Presentations

Unsubscribe

Email Alert Sign Up Confirmation

© 2023 Viridian Therapeutics, Inc. - All rights reserved

Powered By Q4 Inc. 5.136.1.1 (opens in new window)

Privacy Policy
Cookie Policy
Terms of Use
Site Map